Colorectal Cancer Clinical Trials in Nashville

Showing 261-280 of 314 trials

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

NCT00207155

The purpose of this study is to predict response to Erbitux as a single agent in patients with metastatic colon cancer

Eli Lilly and Company110 participantsStarted Dec 2003

Duarte, California, United States • Tampa, Florida, United States • Baltimore, Maryland, United States +11 more locations

COMPLETEDPhase 1< 1 mile

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

NCT00397384

This phase I trial is studying the side effects and best dose of erlotinib hydrochloride when given together with cetuximab and to see how well they work in treating patients with advanced gastrointestinal cancer, head and neck cancer, non-small cell lung cancer, or colorectal cancer. Erlotinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as cetuximab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor cells and help kill them or carry tumor-killing substances to them. Erlotinib hydrochloride and cetuximab may also stop the growth of tumor cells by blocking blood flow to the tumor. Giving erlotinib hydrochloride together with cetuximab may kill more tumor cells.

Adenocarcinoma of the ColonAdenocarcinoma of the RectumAdvanced Adult Primary Liver Cancer+64 more

National Cancer Institute (NCI)43 participantsStarted Jan 2007

Nashville, Tennessee, United States

An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastic Colorectal Cancer

Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer

Colorectal Cancer Trials in Other Cities

FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

Phase I Study of Cetuximab With RO4929097 in Metastatic Colorectal Cancer

Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer

Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery

Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

A Trial of Tivozanib (AV-951) in Combination With Capecitabine (Xeloda®) in Subjects With Advanced Solid Tumors

Comparison of Three Chemotherapy Regimens in Treating Patients With Metastatic Colorectal Cancer

Study to Evaluate the Safety, Tolerability and Efficacy of FOLFOX + CT-011 Versus FOLFOX Alone

Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies

Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer

Vaccine Therapy and Chemotherapy With or Without Tetanus Toxoid Compared With Chemotherapy Alone in Treating Patients With Metastatic Colorectal Cancer

Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing

A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies

Azacitidine and Entinostat in Treating Patients With Metastatic Colorectal Cancer

Vaccine Therapy in Treating Patients With Liver or Lung Metastases From Colorectal Cancer

Educational Intervention With or Without Telephone Counseling in Increasing Colorectal Cancer Screening Compliance in Brothers and Sisters of Patients With Colorectal Cancer

Comparison of Methods to Distend the Colon During Insertion: CO2, Air Insufflation, Water-aided Colonoscopy

A Comparison of Air Insufflation, Water Immersion and Water Exchange Colonoscopy in CRC Screening

Other Conditions in Nashville